JP Morgan Healthcare Conference Highlights
Weight loss drugs are taking center spotlight, but other developing treatments could change how we live. Deidre Woollard caught up with Motley Fool biotech analyst Karl Thiel to discuss: - Biogen’s n...
20 Jan 202426min
The Cointucky Derby
Big-time institutions are jumping into newly-approved Bitcoin spot ETFs, and that could create trouble for some of the bigger players in crypto. (00:21) Jason Moser and Matt Argersinger discuss: - W...
19 Jan 202440min
Banking On The Home Court Advantage
Regional banks are facing strong competition in the battle for your dollars. (00:21) Matt Frankel and Deidre Woollard discuss: - How new rules could change what you pay in overdraft fees. - Why banks...
18 Jan 202430min
di-Spirit Airlines and Uber’s Schnapsidee
The DOJ logs a win against airline consolidation, and Uber takes a sober look at a 2021 acquisition. (00:21) Asit Sharma and Dylan Lewis discuss: - Why JetBlue’s $3.8B acquisition of Spirit Airlines...
17 Jan 202423min
“Focus on the Fastball”
Earnings season begins again and the big banks lead the way. (00:21) Ricky Mulvey and Jason Moser discuss: - The “new” growth engine for Goldman Sachs - The macro risks that Morgan Stanley highlight...
16 Jan 202428min
Wharton Professor on Risk and Returns
Ricky Mulvey caught up with Jules van Binsbergen, a finance professor at the University of Pennsylvania’s Wharton School, to talk about market sentiment, savings goals, and how to prepare for periods ...
14 Jan 202442min
Liz Ann Sonders on the Rolling Recession
Well capitalized companies are taking higher interest rates in stride.The zombies will have more trouble standing up. Liz Ann Sonders is the Chief Investment Strategist at Charles Schwab. Deidre Wool...
13 Jan 202432min
Activist Investors are Acting Up
Twilio’s co-founder and CEO steps down due to activist pressure, and Elliot Management’s $1B stake in Match means changes might be coming. (00:21) Ron Gross and Emily Flippen discuss: - The latest i...
12 Jan 202440min
